Clinical Phenotype, Molecular Architecture, and Survival Follow-Up in NRAS- and KRAS-Mutated Juvenile Myelomonocytic Leukemia.

Cancers (Basel) · 2026 · PMC13406550 · PMID 42512300

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Other routine baseline variables, including age, diagnostic total hemoglobin concentration, WBC, platelet count, spleen size, liver size, sex, lymphadenopathy, and rash, did not show nominally significant differences between the two single-subtype groups.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.